Is Mannkind Corp (NASDAQ: MNKD) Still On The Rise?

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Mannkind Corp is $1.46B. A total of 1.31 million shares were traded on the day, compared to an average of 2.27M shares.

In the most recent transaction, Binder Steven B. sold 25,952 shares of MNKD for 4.66 per share on May 21 ’24. After the transaction, the EVP Special Projects now owns 1,114,553 company shares. In a previous transaction on May 21 ’24, Thomson David sold 23,537 shares at 4.66 per share. MNKD shares that EVP Genl Counsel & Secretary owns now total 873,616.

Among the insiders who sold shares, Binder Steven B. disposed of 3,618 shares on May 13 ’24 at a per-share price of $4.31. This resulted in the EVP Special Projects holding 845,967 shares of MNKD after the transaction. In another insider transaction, Thomson David sold 3,047 shares at $4.31 per share on May 13 ’24. Company shares held by the EVP Genl Counsel & Secretary now total 783,446.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, MNKD has a high of $5.75 and a low of $3.17.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. MNKD’s latest balance sheet shows that the firm has $204.12M in Cash & Short Term Investments as of fiscal 2021. There were $282.24M in debt and $48.35M in liabilities at the time. Its Book Value Per Share was -$0.85, while its Total Shareholder’s Equity was -$209.35M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MNKD is Buy with a score of 4.60.

Most Popular

Related Posts